These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31231091)

  • 21. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
    Yan L; Na W; Shan K; Xiao-Wei M; Wei G; Shu-Cheng C
    Int J Gynecol Cancer; 2008; 18(1):30-5. PubMed ID: 17466040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation screening of the CDKN2A promoter in melanoma families.
    Harland M; Holland EA; Ghiorzo P; Mantelli M; Bianchi-Scarrà G; Goldstein AM; Tucker MA; Ponder BA; Mann GJ; Bishop DT; Newton Bishop J
    Genes Chromosomes Cancer; 2000 May; 28(1):45-57. PubMed ID: 10738302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classifying variants of CDKN2A using computational and laboratory studies.
    Miller PJ; Duraisamy S; Newell JA; Chan PA; Tie MM; Rogers AE; Ankuda CK; von Walstrom GM; Bond JP; Greenblatt MS
    Hum Mutat; 2011 Aug; 32(8):900-11. PubMed ID: 21462282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis.
    Peng F; Hu D; Gu C; Li X; Li Y; Jia N; Chu S; Lin J; Niu W
    Gene; 2013 Dec; 531(2):435-43. PubMed ID: 24012816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of CDKN2A rs3731249, rs11515, and rs3088440 polymorphisms on cancer risk.
    Dong Y; Wang X; Yang YW; Liu YJ
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):40-44. PubMed ID: 28466822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel CDKN2A mutation detected in Spanish melanoma pedigree.
    de Torre C; Martínez-Escribano J
    Exp Dermatol; 2010 Aug; 19(8):e333-5. PubMed ID: 20653773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline splicing mutations of CDKN2A predispose to melanoma.
    Loo JC; Liu L; Hao A; Gao L; Agatep R; Shennan M; Summers A; Goldstein AM; Tucker MA; Deters C; Fusaro R; Blazer K; Weitzel J; Lassam N; Lynch H; Hogg D
    Oncogene; 2003 Sep; 22(41):6387-94. PubMed ID: 14508519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.
    Soto JL; Cabrera CM; Serrano S; López-Nevot MA
    BMC Cancer; 2005 Apr; 5():36. PubMed ID: 15819981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
    Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
    Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline mutation of ARF in a melanoma kindred.
    Hewitt C; Lee Wu C; Evans G; Howell A; Elles RG; Jordan R; Sloan P; Read AP; Thakker N
    Hum Mol Genet; 2002 May; 11(11):1273-9. PubMed ID: 12019208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
    Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
    Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
    Orlow I; Begg CB; Cotignola J; Roy P; Hummer AJ; Clas BA; Mujumdar U; Canchola R; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Wilcox H; Busam K; From L; Berwick M;
    J Invest Dermatol; 2007 May; 127(5):1234-43. PubMed ID: 17218939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based prevalence of CDKN2A mutations in Utah melanoma families.
    Eliason MJ; Larson AA; Florell SR; Zone JJ; Cannon-Albright LA; Samlowski WE; Leachman SA
    J Invest Dermatol; 2006 Mar; 126(3):660-6. PubMed ID: 16397522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
    Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
    Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.
    Zhai X; Gao J; Hu Z; Tang J; Qin J; Wang S; Wang X; Jin G; Liu J; Chen W; Chen F; Wang X; Wei Q; Shen H
    BMC Cancer; 2006 May; 6():138. PubMed ID: 16723031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.
    Koulermou G; Shammas C; Vassiliou A; Kyriakides TC; Costi C; Neocleous V; Phylactou LA; Pantelidou M
    J Genet; 2017 Mar; 96(1):155-160. PubMed ID: 28360400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
    Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.